vs
Side-by-side financial comparison of HAWTHORN BANCSHARES, INC. (HWBK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
HAWTHORN BANCSHARES, INC. is the larger business by last-quarter revenue ($21.2M vs $13.2M, roughly 1.6× TriSalus Life Sciences, Inc.). On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 12.2%). HAWTHORN BANCSHARES, INC. produced more free cash flow last quarter ($22.8M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 9.1%).
Hawthorn Bancshares, Inc. is a U.S. regional bank holding company operating through its wholly owned subsidiary Hawthorn Bank. It provides a full range of retail and commercial banking services including deposit products, mortgage loans, small business financing, commercial lending, and wealth management solutions, primarily serving individual customers and small to mid-sized enterprises across local communities in Missouri.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
HWBK vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $13.2M |
| Net Profit | — | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 35.7% | -24.8% |
| Net Margin | — | -73.9% |
| Revenue YoY | 12.2% | 59.8% |
| Net Profit YoY | — | 3.5% |
| EPS (diluted) | $0.90 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.2M | $13.2M | ||
| Q3 25 | $20.6M | $11.6M | ||
| Q2 25 | $19.7M | $11.2M | ||
| Q1 25 | $18.8M | $9.2M | ||
| Q4 24 | $18.9M | $8.3M | ||
| Q3 24 | $18.1M | $7.3M | ||
| Q2 24 | $18.2M | $7.4M | ||
| Q1 24 | $17.8M | $6.5M |
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $6.1M | $-10.8M | ||
| Q2 25 | $6.1M | $-8.3M | ||
| Q1 25 | $5.4M | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $4.6M | $-2.4M | ||
| Q2 24 | $4.6M | $-4.3M | ||
| Q1 24 | $4.5M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 35.7% | -24.8% | ||
| Q3 25 | 36.4% | -77.9% | ||
| Q2 25 | 37.9% | -65.4% | ||
| Q1 25 | 35.2% | -79.9% | ||
| Q4 24 | 29.9% | -91.8% | ||
| Q3 24 | 31.1% | -118.9% | ||
| Q2 24 | 31.2% | -111.0% | ||
| Q1 24 | 30.5% | -180.8% |
| Q4 25 | — | -73.9% | ||
| Q3 25 | 29.8% | -93.5% | ||
| Q2 25 | 31.0% | -73.9% | ||
| Q1 25 | 28.7% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | 25.3% | -32.6% | ||
| Q2 24 | 25.5% | -58.8% | ||
| Q1 24 | 25.1% | -204.5% |
| Q4 25 | $0.90 | $-0.22 | ||
| Q3 25 | $0.88 | $-0.96 | ||
| Q2 25 | $0.88 | $-0.27 | ||
| Q1 25 | $0.77 | $-0.39 | ||
| Q4 24 | $0.66 | $-0.38 | ||
| Q3 24 | $0.66 | $-0.12 | ||
| Q2 24 | $0.66 | $-0.21 | ||
| Q1 24 | $0.63 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.3M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $174.2M | $-33.9M |
| Total Assets | $1.9B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.3M | $20.4M | ||
| Q3 25 | $99.9M | $22.7M | ||
| Q2 25 | $100.3M | $26.5M | ||
| Q1 25 | $102.3M | $13.0M | ||
| Q4 24 | $51.0M | $8.5M | ||
| Q3 24 | $54.2M | $11.3M | ||
| Q2 24 | $75.8M | $16.5M | ||
| Q1 24 | $43.5M | $4.0M |
| Q4 25 | $174.2M | $-33.9M | ||
| Q3 25 | $164.9M | $-26.7M | ||
| Q2 25 | $156.8M | $-19.4M | ||
| Q1 25 | $153.4M | $-34.4M | ||
| Q4 24 | $149.5M | $-25.9M | ||
| Q3 24 | $146.5M | $-20.4M | ||
| Q2 24 | $138.2M | $-25.3M | ||
| Q1 24 | $136.6M | $-36.0M |
| Q4 25 | $1.9B | $35.3M | ||
| Q3 25 | $1.9B | $36.5M | ||
| Q2 25 | $1.9B | $41.3M | ||
| Q1 25 | $1.9B | $28.6M | ||
| Q4 24 | $1.8B | $24.0M | ||
| Q3 24 | $1.8B | $27.5M | ||
| Q2 24 | $1.8B | $32.4M | ||
| Q1 24 | $1.8B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.9M | $-2.5M |
| Free Cash FlowOCF − Capex | $22.8M | $-2.5M |
| FCF MarginFCF / Revenue | 107.9% | -19.1% |
| Capex IntensityCapex / Revenue | 19.3% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $32.7M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.9M | $-2.5M | ||
| Q3 25 | $288.0K | $-3.7M | ||
| Q2 25 | $5.8M | $-7.3M | ||
| Q1 25 | $5.7M | $-4.5M | ||
| Q4 24 | $25.6M | $-5.7M | ||
| Q3 24 | $9.1M | $-10.8M | ||
| Q2 24 | $8.9M | $-13.4M | ||
| Q1 24 | $5.6M | $-10.9M |
| Q4 25 | $22.8M | $-2.5M | ||
| Q3 25 | $-734.0K | $-3.9M | ||
| Q2 25 | $5.1M | $-7.4M | ||
| Q1 25 | $5.5M | $-5.3M | ||
| Q4 24 | $22.6M | $-5.8M | ||
| Q3 24 | $8.1M | $-11.0M | ||
| Q2 24 | $8.4M | $-13.5M | ||
| Q1 24 | $5.1M | $-10.9M |
| Q4 25 | 107.9% | -19.1% | ||
| Q3 25 | -3.6% | -33.9% | ||
| Q2 25 | 25.9% | -66.1% | ||
| Q1 25 | 29.1% | -57.3% | ||
| Q4 24 | 119.7% | -69.7% | ||
| Q3 24 | 44.9% | -149.9% | ||
| Q2 24 | 46.2% | -183.1% | ||
| Q1 24 | 28.5% | -169.3% |
| Q4 25 | 19.3% | 0.3% | ||
| Q3 25 | 5.0% | 1.9% | ||
| Q2 25 | 3.3% | 0.8% | ||
| Q1 25 | 1.5% | 8.2% | ||
| Q4 24 | 15.9% | 0.6% | ||
| Q3 24 | 5.5% | 2.3% | ||
| Q2 24 | 3.0% | 0.8% | ||
| Q1 24 | 3.1% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.94× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.99× | — | ||
| Q2 24 | 1.93× | — | ||
| Q1 24 | 1.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
